Discover 1,307 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,307
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
for
Retroperitoneal Liposarcoma
Location: Columbus OH, Toronto, Atlanta GA, Houston TX
Sponsor: Australia and New Zealand Sarcoma Association
Sex: All
Age: 18+
Code: NCT07377747
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Columbus OH, Chicago IL, Silver Spring MD, Nashville TN,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase 2, Phase 3, Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Columbus OH, Canton OH, Edgewood KY, Indianapolis IN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase 3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
for
Cervical Cancer
Location: Columbus OH, Cincinnati OH, London, Charlottesville VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07216703
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
for
Relapsed Acute Myeloid Leukemia (AML),
Location: Columbus OH, Buffalo NY, Nashville TN, Chapel Hill NC,
Sponsor: Auron Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06846606
Phase 1, Recruiting
Ivosidenib as Post-HSCT Maintenance for AML
for
IDH1 Mutation, Acute Myeloid Leukemia (AML),
Location: Columbus OH, Milwaukee WI, Atlanta GA, Kansas City KS,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT06707493
Phase 2, Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Columbus OH, Lexington KY, Decatur IL, Richmond VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase 2, Phase 3, Recruiting
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Location: Columbus OH, Nashville TN, Milwaukee WI, Chapel Hill NC,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 19+
Code: NCT06974786
Phase 2, Recruiting
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
for
Malignant Neoplasm
Location: Columbus OH, Toronto, Hackensack NJ, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06979596
Phase 2, Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Location: Columbus OH, Cincinnati OH, Charlottesville VA,
Sponsor: UroGen Pharma Ltd.
Sex: All
Age: 18+
Code: NCT06774131
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: Columbus OH, Cincinnati OH, Maumee OH, Indianapolis IN,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase 3, Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Columbus OH, Pittsburgh PA, Chicago IL, Toronto,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06064877
Phase 3, Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Columbus OH, Chicago IL, Toronto, Milwaukee WI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT04973605
Phase 1, Phase 2, Recruiting
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
for
Germ Cell Tumor
Location: Columbus OH, Oak Lawn IL, Chicago IL, Park Ridge IL,
Sponsor: University of Sydney
Sex: All
Age: 11 - 50
Code: NCT02582697
Phase 3, Recruiting
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
for
Multiple Myeloma
Location: Columbus OH, Detroit MI, Indianapolis IN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05137054
Phase 1, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Columbus OH, Centerville OH, Canton OH, Cleveland OH,